IL-6/JAK/STAT3 signaling in breast cancer metastasis: biology and treatment

SG Manore, DL Doheny, GL Wong, HW Lo - Frontiers in oncology, 2022 - frontiersin.org
Breast cancer is the most commonly diagnosed cancer in women. Metastasis is the primary
cause of mortality for breast cancer patients. Multiple mechanisms underlie breast cancer …

In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform

ME Katt, AL Placone, AD Wong, ZS Xu… - … in bioengineering and …, 2016 - frontiersin.org
In vitro tumor models have provided important tools for cancer research and serve as low-
cost screening platforms for drug therapies; however, cancer recurrence remains largely …

Transcriptional regulation of myeloid-derived suppressor cells

T Condamine, J Mastio… - Journal of Leucocyte …, 2015 - academic.oup.com
Myeloid-derived suppressor cells are a heterogeneous group of pathologically activated
immature cells that play a major role in the negative regulation of the immune response in …

STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges

GL Wong, SG Manore, DL Doheny, HW Lo - Seminars in cancer biology, 2022 - Elsevier
Breast cancer is the most commonly diagnosed cancer and second-leading cause of cancer
deaths in women. Breast cancer stem cells (BCSCs) promote metastasis and therapeutic …

Oxidative DNA damage induced by ROS-modulating agents with the ability to target DNA: A comparison of the biological characteristics of citrus pectin and apple …

F Salehi, H Behboudi, G Kavoosi, SK Ardestani - Scientific reports, 2018 - nature.com
DNA targeting anticancer agents have been very successful in clinic, especially, when used
in combinatorial therapy. But unfortunately, they often exhibit high levels of toxicity towards …

Feedback activation of STAT3 as a cancer drug-resistance mechanism

C Zhao, H Li, HJ Lin, S Yang, J Lin, G Liang - Trends in pharmacological …, 2016 - cell.com
Signal transducer and activator of transcription 3 (STAT3) plays crucial roles in several
cellular processes such as cell proliferation and survival, and has been found to be …

Emerging roles of aldehyde dehydrogenase isoforms in anti-cancer therapy resistance

M Zanoni, S Bravaccini, F Fabbri, C Arienti - Frontiers in medicine, 2022 - frontiersin.org
Aldehyde dehydrogenases (ALDHs) are a family of detoxifying enzymes often upregulated
in cancer cells and associated with therapeutic resistance. In humans, the ALDH family …

Stimuli-responsive polymeric prodrug-based nanomedicine delivering nifuroxazide and doxorubicin against primary breast cancer and pulmonary metastasis

L Luo, F Xu, H Peng, Y Luo, X Tian, G Battaglia… - Journal of Controlled …, 2020 - Elsevier
Functionalized drug delivery systems against malignant lung metastasis of breast cancer
have been extensively studied, while metastasis remains a challenging issue. We propose a …

Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment

M Huo, Y Zhao, AB Satterlee, Y Wang, Y Xu… - Journal of Controlled …, 2017 - Elsevier
Abstract Development of an effective treatment against advanced tumors remains a major
challenge for cancer immunotherapy. We have previously developed a potent mannose …

Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?

JD Beebe, JY Liu, JT Zhang - Pharmacology & therapeutics, 2018 - Elsevier
Signal transducer and activator of transcription 3 (STAT3) controls many biological
processes including differentiation, survival, proliferation, and angiogenesis. In normal …